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ABSTRACT: Untargeted plasmid integration into mammalian cell
genomes remains a poorly understood and inefﬁcient process. The
formation of plasmid concatemers and their genomic integration has been
ascribed either to non-homologous end-joining (NHEJ) or homologous
recombination (HR) DNA repair pathways. However, a direct involvement of
these pathways has remained unclear. Here, we show that the silencing of
many HR factors enhanced plasmid concatemer formation and stable
expression of the gene of interest in Chinese hamster ovary (CHO) cells, while
the inhibition of NHEJ had no effect. However, genomic integration was
decreased by the silencing of speciﬁc HR components, such as Rad51, and
DNA synthesis-dependent microhomology-mediated end-joining (SD-
MMEJ) activities. Genome-wide analysis of the integration loci and junction
sequences validated the prevalent use of the SD-MMEJ pathway for transgene
integration close to cellular genes, an effect shared with matrix attachment
region (MAR) DNA elements that stimulate plasmid integration and
expression. Overall, we conclude that SD-MMEJ is the main mechanism
driving the illegitimate genomic integration of foreign DNA in CHO cells, and
we provide a recombination engineering approach that increases transgene
integration and recombinant protein expression in these cells.
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Introduction
Spontaneous integration of non-viral DNA vectors into the genome
of eukaryotic cells is a widely exploited process in research and
biotechnology. Its molecular basis, however, remains incompletely
understood. It is believed to rely on cellular DNA repair
mechanisms, as it is favored by the presence of free DNA ends
in the vector resembling double stranded breaks (DSBs). The two
major pathways responsible for DSB repair in eukaryotic cells are
non-homologous end-joining (NHEJ) and homologous recombina-
tion (HR) (Jackson, 2002). NHEJ is a fast mechanism that efﬁciently
joins DNA ends with little processing (Mao et al., 2008). In contrast,
HR is a slow, multi-step process requiring resection of one of the
two DNA strands and pairing to a homologous DNA template for
repair. A third group of DSB repair pathways, believed to function
when the main repair mechanisms are impaired, are collectively
termed microhomology-mediated end joining (MMEJ). MMEJ is a
still poorly characterized family of pathways, also referred to as
alternative or backup non-homologous end-joining (alt- or B-
NHEJ), which requires short (2–25 nt) homologies to align broken
DNA strands before joining (Boboila et al., 2010; Gigi et al., 2014; Oh
et al., 2014; Paul et al., 2013). Another hallmark of this process is the
occurrence of large deletions and, less frequently, insertions of
sequences copied from other parts of the genome, termed
templated inserts (Ma et al., 2003; Merrihew et al., 1996). MMEJ
shares DNA strand resection with HR, implying that it may partially
rely on HR enzymes (Decottignies, 2007; Dinkelmann et al., 2009;
Ma et al., 2003; Truong et al., 2013). Several mechanisms proposed
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to mediate chromosomal rearrangements associated with human
genetic disorders were shown to rely on MMEJ (Costantino et al.,
2014; Hastings et al., 2009; Hicks et al., 2010; Lee et al., 2007;
Villarreal et al., 2012). Finally, another variant of MMEJ, termed
synthesis-dependent MMEJ (SD-MMEJ), was also proposed to
repair DSBs in the absence of pre-existing homology (Yu and
McVey, 2010). In this latter mechanism, the microhomologies
required for the MMEJ pathway are synthetized de novo by an
accurate non-processive DNA polymerase. While all of these
mechanisms may be mechanistically different, they possess several
common features, such as the annealing of single stranded DNA
ends at microhomology regions and the priming of low-processivity
DNA polymerization.
Plasmid integration into the genome of eukaryotic cells is an overall
inefﬁcient process, occurring in a minor proportion of cells that take up
the exogenous DNA. It was shown to involve two major steps: (i)
recombination between vector molecules to form multimeric transgene
arrays termed concatemers and (ii) the recombination of the resulting
concatemers with the genome, usually at a single or at few chromosomal
loci (Folgeret al., 1982;Grandjean et al., 2011;Kohli et al., 1998). TheDSB
repair pathways responsible for transgene concatemerization remain
currently unclear. In mammalian cells, this process was attributed to HR
(Folger et al., 1982; Wong and Capecchi, 1987), while NHEJ appeared to
be involved in zebraﬁsh embryos and rice (Dai et al., 2010; Kohli et al.,
1998). In addition, some studies suggested that alternative pathwaysmay
also play a role in the joining of extrachromosomal DNAends (Lundberg
et al., 2001). Similarly, the mechanism mediating the recombination of
the transgene with the genome remains to be fully identiﬁed. NHEJ is
considered to mediate the majority of integration events in eukaryotic
cells, while HR may be responsible for a smaller proportion of genomic
integrations (W€urtele et al., 2003). However, there is evidence that
distinct repair pathways may also be implicated in this process (Iiizumi
et al., 2008; Merrihew et al., 1996).
We previously reported that plasmid integration is enhanced by
the presence of matrix attachment regions (MARs), which are
epigenetic regulatory DNA elements that participate in the
formation of chromatin boundaries and augment transcription
(Galbete et al., 2009; Girod et al., 2007; Grandjean et al., 2011;
Majocchi et al., 2014). MARs are thus widely used to sustain
elevated transgene expression, as well as to prevent epigenetic
silencing effects by blocking the propagation of heterochromatin
(Allen et al., 2000; Harraghy et al., 2008; Zahn-Zabal et al., 2001).
Their action to increase genomic integration and plasmid copy
number suggested that stimulating recombination may constitute
an additional mechanism by which MARs increase transgene
expression (Girod et al., 2007; Grandjean et al., 2011). Thus, in the
present study, we sought to identify the pathway(s) responsible for
the integration of MAR-containing or -devoid plasmids into the
genome of cultured cells.
Using siRNA-mediated knock-down approach, we show that a
subset of alternative repair mechanisms resembling SD-MMEJ may
be preferentially used by CHO cells for the spontaneous integration
of foreign DNA into their genome. This ﬁnding was conﬁrmed by
the characterization of plasmid-to-genome junction sequences,
which were found to display an SD-MMEJ pattern. Finally, we
demonstrate that MAR elements and SD-MMEJ favor transgene
integration into permissive chromatin loci, and that the inhibition
of competing recombination pathways can be used to improve the
expression of recombinant proteins.
Materials and Methods
Cells, Plasmids, and siRNA
Adherent Chinese hamster ovary (CHO) DG44 cells (Urlaub and
Chasin, 1980) were cultivated in DMEM/F-12þ GlutaMAXTM
supplemented with 1 HT and 10% fetal bovine serum (Gibco,
Invitrogen), and with the antibiotic-antimycotic solution (Sigma–
Aldrich, #A5955). Suspension-adapted CHO K1 derived cells
(CHO-M) were cultured in SFM4CHO (HyCloneTM) medium
supplemented with 8mM L-Glutamine (PAA Laboratories GmbH)
and 1 HT (Gibco).
The MAR-devoid pGEGFP, MAR 1-68-containing p1-68-GFP,
pGL3-CMV-DsRed, and pSVpuro expression vectors were described
previously (Supplementary Fig. S1) (Grandjean et al., 2011). The HR
and NHEJ reporter plasmids were kindly provided by V. Gorbunova
(University of Rochester, New York) (Mao et al., 2008). The MMEJ-
speciﬁc GFP reporter assay, based on the pGEGFP vector, was
constructed as described previously (Kostyrko and Mermod, 2015).
Small interfering RNA duplexes, speciﬁcally designed to target the
CHO cell homologs of the DNA repair proteins listed in Tables SI and
SII, were designed and provided by Microsynth AG (Balgach,
Switzerland) (Supplementary Table SIII). Three RNA duplexes were
designed per mRNA to increase the probability of successful knock-
down. It was conﬁrmed experimentally that individual siRNAs had
similar effects on mRNA levels as the siRNA mixes, and it was also
controlled that the siRNA and plasmids were delivered to the cells
with above 90%efﬁciency by using a ﬂuorescently labelled siRNAand
a GFP expression plasmid (data not shown). Three negative (non-
targeting) siRNAs were designed as controls.
Recombination Assays
For HR and NHEJ recombination transient assays, adherent CHO
cells were transfected with HR or NHEJ reporter plasmids digested
with I-SceI, and with the pGL3-CMV-dsRed plasmid to normalize
for transfection efﬁciency, using Fugene 6 (Promega). The pGEGFP
plasmid was transfected in parallel as a positive control of GFP
expression.
For siRNA-mediated knock-downs of DNA repair proteins,
adherent CHO DG44 cells were transfected with equimolar mixes
of three mRNA-speciﬁc or control siRNA duplexes at a ﬁnal
concentration of 50 nM using Lipofectamine RNAiMAX (Invitro-
gen), according to manufacturer’s instructions (Supplementary
Fig. S2A). After 2 days, the siRNA-treated cells were re-transfected
with pGEGFP or p1-68-GFP, and with a puromycin resistance
plasmid pSVpuro (Clontech), using Lipofectamine 2000 (Invitro-
gen). Prior to transfection all plasmids were linearized with PvuI
and puriﬁed by ethanol precipitation. Puromycin (5mg/mL) was
added to the culture medium 24 h after transfection, and stably
transfected cells were selected for 2 weeks. Stable GFP expression
was analyzed by ﬂow cytometry (CyAn ﬂow cytometer, Beckman
Coulter), whereas aliquots of each sample were used for genomic
DNA extraction.
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Colony Formation Assay
To assess the frequency of genomic integration events, CHO DG44
cells were transfected with siRNA duplexes against selected DNA
repair proteins, using the protocol described above (Supplementary
Fig. S2A). Cells were re-transfected 72 h later with pGEGFP or
p1-68-GFP, and pSVpuro, using Lipofectamine 2000 (Invitrogen),
once the effects of the knock-down on cell cycle progression had
disappeared (Kostyrko et al., 2015). The cells were trypsinized and
counted 24 h after the second transfection, and 10000 viable cells
were seeded in complete medium into each well of a 6-well plate.
Puromycin (5mg/mL) was added to the medium 7 h after seeding.
After 10 days of selection, puromycin-resistant colonies were
stained with 0.2%methylene blue and quantiﬁed using ImageJ (U.S.
National Institutes of Health, Bethesda, MD).
Transgene Copy Number Determination and
Quantitative PCR
To analyze the transgene copy number, total genomic DNA was
isolated from cells using the DNeasy puriﬁcation kit (Qiagen). For
quantitative PCR (qPCR), 6 ng of genomic DNAwere analyzed using
the SYBRGreen IMaster kit for the Light Cycler 480machine (Roche)
using AGCAAAGACCCCAACGAGAA and GGCGGCGGTCACGAA as
GFP-speciﬁc primers. The beta-2-microglobulin (B2M) CHO gene
was ampliﬁed as a normalization control using ACCACTCTGAAG-
GAGCCCA and GGAAGCTCTATCTGTGTCAA as primers. The
number of integrated transgene (GFP) copies was calculated using
the B2M gene as a reference, as previously described (Pfafﬂ, 2001).
Characterization of Transgene Integration Sites
To assess which CHO genes were expressed in our culture
conditions, the transcriptome of the suspension-adapted parental
CHO K1 cells was determined by paired-end sequencing using the
Illumina technology by the Next Generation Sequencing Facility of
the University of Lausanne. Expressed coding sequences were
annotated using the Annotation Release 101 of the Chinese hamster
genome assembly (CriGri_1.0, GCF_000223135.1) (Xu et al., 2011).
To identify the plasmid integration sites in polyclonal
populations, CHO K1 cells were electroporated with the MAR-
devoid pGEGFP or the MAR-containing p1-68-GFP plasmids and
with the pSVpuro puromycin resistance construct using the Neon1
transfection system (Invitrogen). After 3 weeks of puromycin
selection, total genomic DNA was isolated from polyclonal cells
using the Genomic-tip G/20 kit (Qiagen). The DNA was sequenced
using the Single Molecule Real-Time (SMRT) technology (Paciﬁc
Biosciences) at the Next Generation Sequencing Facility of the
University of Lausanne. CHO cells transfected with p1-68-GFP were
sequenced using 20 SMRT cells, and those transfected with pGEGFP
required the use of 60 SMRT cells to obtain a similar number of
integration site sequences. Transgene integration sites were
identiﬁed by a custom identiﬁcation pipeline. PacBio ﬁltered
subreads were obtained using the tool DEXTRACTOR (Myers,
unpublished) using the standard settings. Plasmid sequences were
identiﬁed in PacBio ﬁltered subreads with the help of the alignment
tool BLASR (Chaisson and Tesler, 2012). A raw score of at least
500 was chosen as cut-off based on results using PacBio reads
from untransfected CHO cells. Flanking regions of matching
plasmid sequences were extracted and mapped onto the CHO K1
genome using BLASR. 14 CHO genomic integration sites were
identiﬁed in the p1-68-GFP-transfected population and 10 in the
pGEGFP-transfected population. Two sets, one of 14 and one of 10,
different, randomly picked genomic scaffolds of the same length
(10%) as the sample scaffolds were selected as controls. The
Annotation Release 101 of the Chinese hamster genome assembly
(CriGri_1.0, GCF_000223135.1) was used to identify the CHO genes
in the vicinity of the integration sites. The presence of genes near
the plasmid integration position in each of the identiﬁed scaffolds
was compared with an analogous position on a corresponding
control scaffold. An exact binomial test was used to calculate
statistical signiﬁcance between these datasets. Based on this
analysis, integration within 5 kb from an open reading frame (ORF)
was considered as intragenic, whereas integrationwithin 35 kb from
an ORF was deﬁned as gene-proximal.
Suspension-adapted CHO K1 cells were stably transfected in
multiple transfection cycles with plasmid vectors containing the
human MAR X-29 and encoding the light and heavy chains of the
trastuzumab and adalinumab therapeutic antibodies, as previously
described (Le Fourn et al., 2014), with prior PvuI cleavage of the
vectors. Clones expressing the highest amount of the recombinant
proteins were selected for whole genome sequencing (Illumina),
performed by Fasteris SA (Plan-Les-Ouates, Switzerland). Integra-
tion sites were ﬁrst predicted by the in silico identiﬁcation of paired
reads displaying linked plasmid and genomic sequences, and the
predicted junctions were subsequently validated by PCR ampliﬁca-
tion and Sanger sequencing. Identiﬁcation of CHO genes near the
plasmid integration sites was performed as described for the
polyclonal populations.
Analysis of Immunoglobulin-Expressing CHO Cells
To assess the impact of DNA repair protein knock-down on
recombinant protein expression, CHO K1 cells were electroporated
with a negative control siRNA and siRNAs against MDC1, Ligase I,
Rad51, and Rad52 using the Neon1 transfection system (Invitrogen)
(Supplementary Fig. S2B). Two days post transfection the cells were
electroporated with PvuI-linearized human immunoglobulin (IgG1)
expression vectors containing the MAR 1–68 and a puromycin
resistance plasmid (pSVpuro) (Supplementary Fig. S1), using the
Neon1 transfection system (Invitrogen). After 3 weeks of antibiotic
selection the IgG titer in cell culture supernatants was measured by
sandwich ELISA and the speciﬁc productivity was calculated as
described previously (Le Fourn et al., 2014).
Results
Plasmid Integration Does Not Rely on NHEJ or the
Canonical HR Pathway
To assess the possible implication of NHEJ and HR in plasmid
concatemer formation and spontaneous integration into the cell
genome, we silenced the components of these major DSB repair
pathways in CHO DG44 cells using short interfering RNA (siRNA)
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(Supplementary Fig. S3 and Table SI). Efﬁcient reduction of the
target mRNA and/or protein levels by siRNA transfection was
validated experimentally, to insure decreased levels by at least
twofold (Supplementary Figs. S4 and S5).
To evaluate if the knock-down of these genes affects DNA
recombination, we used previously described HR and NHEJ
ﬂuorescent reporter assays based on the repair of transiently
transfected plasmids with a I-SceI-induced DSB in the GFP coding
sequence (Mao et al., 2008; Seluanov et al., 2004). These assays
enable to evaluate the efﬁciency of extrachromosomal break repair,
and thereby may provide an estimation of HR and NHEJ
involvement in plasmid concatemer formation. We observed that
DSB repair of the HR reporter plasmid was impaired by the knock-
down of the Rad51 HR protein, whereas it was rather increased in
cells treated with siRNAs targeting NHEJ factors (Supplementary
Fig. S6A). This indicated that Rad51 may contribute to the repair of
DSBs in episomal plasmids. Interestingly, the knock-down of the
remaining HR factors had no detectable effect on GFP reconstitu-
tion in this assay, although there was a very signiﬁcant difference
between the overall effect of knocking-down NHEJ and HR genes, in
line with the previously reported competition between these
pathways (Neal et al., 2011). In contrast, the occurrence of GFP
expression from the NHEJ reporter was not altered by any of the
NHEJ-targeting siRNAs (Supplementary Fig. S6B), implying that
NHEJ is not prominently used to rejoin episomal DSBs in CHO cells
or that alternative end-joining pathways may be more active than
NHEJ.
We further assessed the recombination mechanisms involved in
plasmid concatemer formation and genomic integration by stably
transfecting the siRNA-treated CHO cells with plasmids carrying
the GFP reporter and a puromycin resistance gene (Supplementary
Fig. S2A). The average number of integrated GFP copies was
measured in antibiotic-resistant polyclonal populations, so as to
assess the efﬁciency of plasmid concatemerization prior to genomic
integration. Since expression from individual plasmids can be
inﬂuenced by the surrounding chromatin environment, the level of
GFP ﬂuorescence and its normalization to the transgene copy
number was used to estimate plasmid integration within
transcription permissive or non-permissive areas of the genome.
Finally, we measured the efﬁciency of plasmid genomic integration
by quantifying puromycin-resistant colonies arising from cells
that had successfully integrated transgenes into their genome,
focusing on siRNAs that affected GFP expression or plasmid
concatemerization, as well as representative targets from each DSB
repair pathway.
The average GFP expression and plasmid copy number were not
affected by the down regulation of NHEJ activities such as DNA-
PKcs, Ligase IVor Xrcc4, nor was the expression per transgene copy
or the number of antibiotic resistant colonies (Fig. 1A–D). This
indicated that NHEJ activities are not limiting for plasmid
concatemerization and integration within the cell genome.
Stable GFP expression and/or transgene copy numbers were
increased by the knock-down of HR proteins, notably MDC1,
Rad51, Rad52, Rad54, and Brca1 (Fig. 1A and B). The knockdown
of these proteins had overall little effect on gene expression when
normalized to the copy number, indicating that the increased
expression observed upon HR gene knockdown resulted mostly
from an increased copy number rather than from preferential
plasmid integration into transcription-permissive chromatin
(Fig. 1C). These observations indicated that HR activities may
oppose a mechanism that mediates plasmid concatemerization
prior to genomic integration. However, the knock-down of proteins
having an effect on plasmid concatemerization and/or GFP
expression, such as MDC1 and Rad51, strongly decreased the
number of puromycin-resistant colonies (Fig. 1D), indicating that
these components of the HR pathway may mediate transgene
genomic integration. Interestingly, the frequency of integration was
not affected by the knock-down of other components of HR, such
as Rad52, Rad54, or Brca1, despite their effect on transgene
concatemerization and expression. These ﬁndings implied that
some HR activities are required for genomic integration whereas
others are not, suggesting the occurrence of non-canonical HR-
related integration mechanisms.
MMEJ-Type Mechanisms Mediate Plasmid
Concatemerization and Genomic Integration
Given that neither the NHEJ nor the canonical HR pathway may be
involved in plasmid concatemerization prior to genomic integra-
tion, we speculated that this could involve MMEJ-related
mechanisms active in eukaryotic cells with impaired NHEJ
and/or HR, but that may share early 50 strand resection events
with the HR pathway (Supplementary Fig. S3 and Table SII)
(Decottignies, 2007; Ma et al., 2003).
Knock-down of most MMEJ proteins had a moderate effect on
plasmid integration or expression, possibly because these pathways
may be masked by other repair mechanisms in the absence of
induced DNA damage, as was the case here (Fig. 2A–C).
Nevertheless, we observed a small decrease in GFP copy number
upon the knock-down of DNA polymerase u (Pol theta), suggesting
that this polymerase might be involved in plasmid concatemeriza-
tion, although the potential involvement of other DNA polymerases
cannot be excluded. Interestingly, the knock-down of Ligase I had
an opposite effect (Fig. 2A and B). Moreover, the depletion of this
ligase strongly inhibited plasmid genomic integration (Fig. 2D). A
recent study suggested the existence of two branches of the MMEJ-
related end-joining pathways, one of which may depend on Ligase I
whereas the other would require Ligase III (Oh et al., 2014; Paul
et al., 2013). We thus speculated that upon Ligase I knock-down, the
Ligase III-dependent branch could prevail, which may favor
plasmid concatemer formation. In contrast, the pathway responsi-
ble for plasmid genomic integration may be dependent on Ligase I,
as it is suppressed by it’s depletion.
We have recently constructed a MMEJ-speciﬁc GFP reporter
assay, based on principles analogous to the HR and NHEJ reporter
plasmids used above (Kostyrko and Mermod, 2015). Interestingly,
the use of this reporter in CHO cells revealed that the majority of
episomal DSBs were not re-joined by a simple MMEJ pathway.
Instead, the joined sequences of most repaired vectors rescued from
the transfected cells resembled the recently proposed alternative
DNA synthesis dependent (SD)-MMEJ mechanism (Yu and McVey,
2010). This pathway relies on a non-processive DNA polymerase,
such DNA polymerase u, to copy short homologous sequences
(2–9 bp) from a different part of the repaired molecule, which can
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then be used to rejoin the DSB (Yousefzadeh et al., 2014; Yu and
McVey, 2010). As a result, the junction sequence consists of a short
duplication (direct or inverted) of a sequence found nearby on the
repaired DNA fragment (Supplementary Fig. S3). Seventy percent of
the analyzed repair products had no pre-existing microhomology
indicative of MMEJ, but they displayed direct or inverted repeat
sequences associated SD-MMEJ, up- or downstream of the repaired
junction (Kostyrko and Mermod, 2015). We thus concluded that
plasmid-to-plasmid joining relies mostly on a SD-MMEJ pathway
potentially involving DNA polymerase u and Ligase III, and that the
simple MMEJ mechanism is seldom used.
MAR Elements Promote Plasmid Integration by
Stimulating SD-MMEJ Pathways
We previously showed that transgene integration in CHO cells is
enhanced three- to fourfold in the presence of matrix attachment
regions (MARs), which are DNA elements that form chromatin
domain boundaries (Girod et al., 2007; Majocchi et al., 2014). A
human MAR, termed MAR 1–68, was found to increase both the
number of transgene copies as well as the frequency of genomic
integration events in CHO cells, which has been previously ascribed
to HR-related mechanisms (Grandjean et al., 2011). However, which
HR-related recombination mechanism may be activated by MAR
elements was not assessed.
To unambiguously identify the recombination mechanism
activated by such elements, we combined the addition of the
human MAR 1–68 in the GFP vector with the siRNA knock-down
approach used earlier. As shown previously, inclusion of the MAR
1–68 enhanced GFP expression and copy number by approximately
ﬁve- and threefold, respectively, when compared to the MAR-devoid
control (Fig. 3A and B). This indicated that the MAR acted in part to
activate plasmid concatemerization, whereas it concomitantly
increased expression per gene copy (Fig. 3C). The presence of the
MAR also increased by around twofold the proportion of cells
having recombined the transgenes into their genome (Fig. 3D),
indicating that it also activated genomic integration.
In the presence of the MAR, the silencing of NHEJ factors had no
effect on transgene expression or copy number, as before
(Fig. 3A and B). In contrast, the knock-down of many HR and
cell cycle control factors yielded very high transgene expression, but
without further increasing the transgene copy number. Consis-
tently, we observed an enhancement of expression per gene copy
upon the knock-down of most HR factors, which was markedly
Figure 1. Effect of HR and NHEJ components knock-down on plasmid genomic integration and expression. CHO cells treated with indicated siRNAs were re-transfected with a
GFP expression plasmid and puromycin resistance vector. Puromycin-resistant stable polyclonal CHO populations were assessed for average GFP fluorescence (A), GFP copy
number (B), GFP expression per transgene copy (C), and the occurrence of puromycin-resistant colonies (D). Values represent mean fold change over control cells not treated with
siRNAs (mock); s.e.m error bars, n 3.
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higher than the increase already mediated by the MAR (Fig. 3C). A
strong inhibition of the frequency of plasmid genomic integration
was again noted upon the knock-down of MDC1 and especially
Rad51 (Fig. 3D). This indicated that these factors and the MARmay
act synergistically to promote transgene genomic integration.
However, upon the knock down of Rad51 and other HR proteins, the
MAR-containing plasmids may have integrated preferentially into
expression-permissive portions of the genome. We therefore
speculated that the MAR acts to promote one or several MMEJ-
related pathways that may direct transgenes into expression-
favoring chromatin structures.
In the presence of the MAR, the knock-down of MMEJ factors
had mostly similar effects on GFP expression and copy number as
observed earlier for the MAR-devoid plasmid, with a small decrease
upon the knock-down of DNA polymerase u, and an increase in the
absence of Ligase I (Fig. 3A and B). Interestingly, the presence of the
MAR seemed to counteract the effect of Ligase I down-regulation on
transgene genomic integration, possibly by reducing the inhibitory
effect of the reduced ligase level, or by stimulating a distinct
recombinationmechanism (Figs. 2C and 3D). Overall, we concluded
that the MAR may activate both concatemerization and genomic
integration processes by stimulating SD-MMEJ-related repair
pathways, and that these pathways may concur with the MAR to
favor integration into expression-permissive genomic loci.
The MAR and SD-MMEJ Pathways Mediate Transgene
Integration Near Cellular Genes
To further assess which of the alternative recombination pathways
may mediate favorable genomic integration events, we analyzed
the genomic integration loci and the DNA sequence of the
genome-plasmid junctions. This was performed on three CHO
clones transfected multiple times with immunoglobulin (IgG)
expression vectors containing the human MAR X-29 and selected
for high stable expression of the therapeutic protein. To do so, we
used a whole genome sequencing approach on these clones and
Figure 2. Effect of MMEJ components knock-down on plasmid genomic integration and expression. CHO cells were treated with siRNAs against the indicated MMEJ genes
and processed as described in the legend to Figure 1. The average GFP fluorescence (A), GFP copy number (B), GFP expression per transgene copy (C), and frequency of genomic
integration events (D) were assessed and represented as in Figure 1 (n 3).
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devised a software to identify paired sequence reads pertaining to
the plasmid and the CHO genome. Six integration sites in one
clone (BS01) and two in the other clones (BS03 and Cp33/64)
were predicted in silico and validated experimentally by PCR
ampliﬁcation and DNA sequencing. The occurrence of the
predicted number of plasmid integration loci was further
validated by FISH for two of the analyzed clones (Supplementary
Fig. S7).
From the ﬁve integration sites where the junction sequences were
validated experimentally on both sides of the transgenes, two had
large deletions (913 bp in BS01 and 320 bp in Cp33/64), as expected
from MMEJ-related mechanisms (Supplementary Table SIV
and Fig. 4). In 5 of the 15 experimentally validated junctions, we
noted the presence of short (1–3 bp) or long (60–100 bp) templated
inserts, suggesting the involvement of a DNA polymerase in the
repair process, a hallmark of the SD-MMEJ mechanism (Fig. 5). All
analyzed junction sequences ﬁtted well to the SD-MMEJ model,
although 5 out of 15 junctions also covered pre-existing micro-
homologies (2 nt), and thus could also be explained by simple
MMEJ. Interestingly, no integration site could be explained by HR.
Although NHEJ cannot be fully excluded, as it does not strictly
require extensive homology, the SD-MMEJmechanismmore readily
explains the presence of extended deletions and templated inserts.
Moreover, no junction lacking any type of microhomology was
observed. Overall, these results conﬁrmed that the genomic
integration of MAR-containing plasmids predominantly involves a
SD-MMEJ pathway.
Out of the 10 integration events, eight had occurred within or
near cellular genes, whereas only two were intergenic. Seven out of
these eight gene-proximal integrations were found in or close to an
expressed gene (Supplementary Table SV), suggesting that most
integration events had occurred in transcriptionally active genomic
loci. These results further suggested that the MAR-containing
plasmids preferably integrate within- or in close proximity- to
expressed CHO genes. To assess whether this indeed resulted from
the presence of the MAR in the IgG expression vector or from the
selection of highly expressing clones, we directly compared the
integration loci of MAR-containing and MAR-devoid GFP
expression vectors in polyclonal cell populations.
Analysis of the integration sites identiﬁed from the whole
genome sequencing of these cells revealed that, in presence of the
MAR, plasmids indeed often integrated close to cellular genes
(10/14 loci) (Supplementary Table SV and Fig. S8). This result was
signiﬁcantly different from random (P¼ 0.05), indicating that the
MAR may stimulate genomic integration into chromatin regions
permissive for transgene expression. In the cells transfected with
the MAR-devoid plasmid, integration in the vicinity of genes was
not signiﬁcantly enriched (Supplementary Table SV and Fig. S8B).
Figure 3. Effect of aMAR element and recombination gene knock-down on plasmid genomic integration and expression. The effect of the inclusion of aMAR element on stable
GFP expression (A), GFP copy number (B), GFP expression per transgene copy (C), and the frequency of genomic integration events (D), were assessed as described for Figures 1
and 2, except that siRNA-treated cells were re-transfected with GFP or MAR-GFP vectors, as indicated (n 3).
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Furthermore, these cells required threefold more sequencing reads
to identify a comparable number of integration loci as obtained
from the cells transfected with the MAR, further indicating that
genomic integration events were less frequent in the absence of the
MAR.
Interestingly, all cellular genes near the integration loci of MAR-
devoid plasmids were transcribed in the parental CHO cells
(Supplementary Table SV and Fig. S9). This suggested that, in the
absence of the MAR, the cells had to integrate the transgenes into
transcriptionally active chromatin in order to express the selection
gene at a sufﬁcient level to survive antibiotic selection. This may
explain the strong decrease in cell survival upon the knock-down of
Rad51, as this protein was recently reported to be primarily
responsible for DSB repair in transcriptionally active chromatin
(Aymard et al., 2014). In contrast, presence of the MAR seemed to
alleviate the need to integrate transgenes into transcribed genomic
sequences, as only half of the CHO genes close to integration sites
were found to be transcriptionally active. This indicated that the
MAR itself may ensure high expression of transgenes integrated in
non-transcribed DNA, likely due to its previously reported
transcription-enhancing properties (Galbete et al., 2009; Majocchi
et al., 2014). Taken together, these results suggested that MAR
elements may promote transgene integration into gene-rich
chromatin regions by stimulating an SD-MMEJ mechanism.
MARs and HR or SD-MMEJ Knock-Down Improve
Recombinant Protein Expression
The transient knock-down of MDC1, Rad51, Rad52, and Ligase I
was found to mediate the highest and most homogeneous GFP
ﬂuorescence from polyclonal pools of cells stably transfected with
the MAR-GFP vector (Fig. 6A). To ascertain whether the knock-
down of these speciﬁc HR and/or SD-MMEJ activities may be used
in conjunction with MAR elements as a general approach to boost
the expression of recombinant proteins, we similarly assessed
vectors encoding a therapeutic IgG1 immunoglobulin, using a
suspension-adapted CHO K1 cell line derivative suitable for the
production of therapeutics. CHO cells treated with siRNAs against
Rad51, Rad52, MDC1, or Ligase I were subsequently re-transfected
with MAR-containing vectors for the human IgG1 light and heavy
chains (Supplementary Fig. S2B). Polyclonal populations were then
assessed for speciﬁc antibody secretion, which revealed that prior
treatment with Rad52, MDC1, or Ligase I siRNAs increased stable
IgG expression by approximately twofold relative to the untreated
cells (Fig. 6B). The high productivity levels observed from these
polyclonal populations, up to over six picograms per cell per day
(PCD), are usually only observed from monoclonal populations
obtained from the screening of hundreds of individual cell clones, to
identify the most productive ones. Interestingly, Rad51 depletion in
Figure 4. Example of a plasmid-to-genome junction and underlying SD-MMEJ mechanism. The integration site and junction sequence used in this example is taken from
Supplementary Table SIV (clone BS01, integration site #2, right junction). P1/P2, primer repeats; mh1/mh2, microhomology repeats. Adapted from Yu and McVey (2010).
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CHO K1 cells had a weaker effect on transgene expression than in
CHO DG44 cells. This could be due to the combination of
mechanical stress associated with growth as cell suspension in
shake ﬂasks, antibiotic selection and the deleterious effect of Rad51
knock-down. Consistently, we observed that CHO K1 cells treated
with Rad51 siRNA grew much slower than the cells treated with
other siRNAs, and only a small number of cells survived selection
(data not shown). We hypothesize that the population of CHO K1
cells that recovered from selection represented cells which retained
some Rad51 activity, and which thus did not have a large increase of
plasmid concatemerization and overall expression.
In conclusion, the increase in expression mediated by Rad52,
MDC1, and Ligase I knock-down could be observed for distinct
recombinant proteins, and from the use of distinct CHO cell lines
and vectors. We concluded that the production of therapeutic
proteins in CHO cells may be signiﬁcantly improved by transiently
altering their DSB repair properties during transfection and by
incorporating MAR elements in the vector.
Discussion
Eukaryotic cells have developed many defense mechanisms that
detect and repair DNA double stranded breaks, one of the most
deleterious types of DNA damage. The two canonical pathways
responsible for DSB repair are HR and NHEJ. However, recent
evidence indicated that these two mechanisms may not sufﬁce to
repair all DSBs, and that several alternative pathways, collectively
termed MMEJ or alt-NHEJ, also exist in eukaryotic cells (Gigi et al.,
2014; Truong et al., 2013). These later processes are often obscured
by the main repair mechanisms, which may predominate in normal
cells. Furthermore, their components are still poorly characterized
and there was no simple assay to speciﬁcally detect them, rendering
their study difﬁcult (Kostyrko and Mermod, 2015). However, they
are now attracting increasing attention, notably in oncology, since
these “illegitimate” recombination pathways were shown to be more
prevalent in tumor cells and to cause chromosomal rearrangements
leading to cancer (Bentley et al., 2004; Simsek et al., 2011; Tobin
et al., 2012; Zhang and Jasin, 2011).
Here, we found that NHEJ and HR are not the main pathways
responsible for non-speciﬁc recombination in CHO cells, as
required for plasmid genomic integration in these cells. Rather, we
found that the absence of several HR factors augmented plasmid
concatemerization, implying that HR proteins may compete with
one or more DSB repair pathways that mediate this process. In
contrast, speciﬁc HR proteins, such as Rad51, were required for
efﬁcient transgene recombination with the genome, whereas the
silencing of downstream HR proteins had no effect. This suggested
the involvement of other mechanisms, distinct from the canonical
NHEJ or HR pathways but nevertheless requiring DNA homology,
such as MMEJ-related pathways. Consistently, the knock-down of
Ligase I, a protein reported to play a role in alternative DSB repair
pathways, was found to alter plasmid genomic integration.
Figure 5. Example of a plasmid-to-genome junction and SD-MMEJ mechanism requiring a templated insertion. (A) A scheme showing the mechanism of plasmid (dark green)
joining with the genome (blue). Another fragment of the plasmid (light green) serves as an adaptor providing themicrohomologies required for joining and becomes incorporated into
the junction as a templated insert. (B) Sequences of plasmid and genome fragments shown in panel A. The integration site and junction sequence used in this example is taken from
Supplementary Table SIV (clone BS01, integration site #1, right junction). P1/P2 and P3/P4, primer repeats; mh1/mh2 and mh3/mh4, microhomology repeats.
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As the majority of rejoined plasmid extremities displayed
microhomology patterns and templated inserts, we attribute
these end-joining events to the SD-MMEJ mechanism proposed
by Yu and McVey (2010). Indeed, both plasmid-to-plasmid and
plasmid-to-genome fusion sequences were also present as direct
or inverted repeats near the junctions, occasionally accompanied
by templated inserts. However, the knock down of speciﬁc
SD-MMEJ activities had distinct effects on plasmid concatemer
formation and on genomic integration, suggesting the occurrence
of multiple SD-MMEJ pathways. One of these pathways, which
may rely on DNA polymerase u and Ligase III, appears to mediate
plasmid concatemerization. The other SD-MMEJ pathway, which
may involve the activity of Ligase I, appears to mediate the
recombination of plasmid concatemer with the genome, as
indicated by the ﬁnding that the lack of this ligase nearly
abolished genomic integration of the GFP vector. Taken together,
these results imply that concatemer formation and integration of
MAR-devoid plasmids may be mediated by sets of proteins
belonging to distinct branches of the SD-MMEJ pathways, as
proposed in Figure 7.
Interestingly, we observed that the knock down of Rad51 had
similar effects as the silencing of Ligase I, implying that they
contribute to the same pathway mediating genomic integration of
exogenous DNA. The mechanismmediating microhomology search
of the SD-MMEJ pathway remains mostly uncharacterized, but it
may involve DSB repair components that are common to other
mechanisms. In this model, the Ligase I-dependent SD-MMEJ
pathway may lie downstream of the search for a homologous DNA
strand by Rad51, as in canonical HR (Fig. 7). However, the lack of
extended homology may preclude the productive cooperation of
Rad51 with its accessory proteins, preventing extended strand
invasion and the successful completion of HR. End-joining would
then rather be performed by Ligase I-dependent SD-MMEJ, as a
salvage repair pathway, since it only requires short homology
regions as shared by the plasmid and cell genome. When such
microhomologies are not available, they may be provided by an
adaptor DNA stretch copied from nearby plasmid or genome
sequences, leading to the insertion of a templated insert separating
the joined sequences (Fig. 5). We hypothesize that the enzyme
involved in the synthesis of the templated insert may be DNA
Figure 6. Engineering of the transgene integration process for improved expression. (A) Adherent CHO cells transfected with the indicated siRNAs or left untreated (control),
were re-transfected with a GFP or MAR-GFP vector, as indicated, and selected for antibiotic resistance. GFP fluorescence profiles of polyclonal cell pools and corresponding
fluorescence microscopy pictures are shown. (B) Specific IgG productivity in polyclonal, suspension-adapted CHO cells treated as for panel A, except that they were re-transfected
with the MAR-containing IgG1 expression vectors. Values represent the average fold change in IgG secretion (in picograms/cell/day) as compared to the cells not treated with
siRNAs (control); s.e.m error bars, n¼ 3.
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polymerase d, which together with Ligase I participates in DNA
replication and long patch base excision repair (BER) (Stucki et al.,
1998). In human cells, a break-induced replication (BIR)
mechanism responsible for the repair of one-ended DSBs was
also recently shown to rely on POLD3, a DNA polymerase d subunit,
and to involve microhomologies (Costantino et al., 2014; Lydeard
et al., 2007). Nevertheless, whether the Rad51-dependent SD-MMEJ
pathway proposed here may be related to BIR remains to be
established.
Inclusion of a MAR element also increased plasmid concateme-
rization, suggesting that it can act to activate the processing of
linearized plasmid extremities by a Ligase I-independent SD-MMEJ
mechanism. In addition, the MAR presence increased genomic
integration and dampened the inhibitory effect of Ligase I
downregulation, whereas it did not abolish the requirement for
Rad51. These ﬁndings suggest a preferential use of the Ligase
I-dependent SD-MMEJ mechanism for the genomic integration of
the MAR-devoid plasmid, whereas the presence of the MAR may
stimulate the use of a repair pathway downstream of Rad51 that
may involve a distinct ligase, for example, Ligase III.
The molecular mechanisms by which MARs may promote
SD-MMEJ-mediated recombination could involve their AT-rich
cores, which possess a high potential for double helix denaturation
(Bode et al., 1992; Platts et al., 2006), or their enrichment in
topoisomerase II cleavage sites and so-called fragile sites that may
be the hot spots of DNA breakage and repair (Jackson et al., 2003;
Sperry et al., 1989; Svetlova et al., 2001). Consistently, these sites
were previously reported to be preferred targets of plasmid
integration (Rassool et al., 1991). MAR elements were also proposed
to mediate DNA replication initiation in mammalian somatic cells
(Debatisse et al., 2004). Thus, they might associate with DNA
replication machinery components also involved in MMEJ-related
mechanisms (e.g., Pold3, Ligase I), thereby contributing to the
repair of DSBs arising at replication forks (Truong et al., 2013).
In this study, we identiﬁed SD-MMEJ as the primary mechanism
driving plasmid integration in the genome of CHO cells. We propose
the occurrence of two distinct SD-MMEJ branches relying on
different subsets of proteins, both of which are stimulated by MAR
elements, to increase transgene copy number and to preferentially
target plasmid DNA into potentially expression-permissive, gene-
Figure 7. Revised model of the major CHO cell DSB repair pathways. A novel model describing the possible interplay of the NHEJ, HR, MMEJ, and two distinct SD-MMEJ
pathways involved in DSB repair in CHO cells, as modified from Supplementary Figure S3. Although the junction sequences resulting from both SD-MMEJ pathways are similar, the
Ligase I-dependent SD-MMEJ requires the homology-searching Rad51 protein, and it may provide a fallback mechanism in the absence of extensive homology, as required to
complete HR. Activities that initiateMMEJ and Ligase III-dependent SD-MMEJ remain to be identified, but the presence or absence of pre-existing microhomologies may dictate the
choice between these two pathways.
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rich regions of the genome. Finally, we use this knowledge to
transiently modify the DNA recombination properties of CHO cells
to improve the expression of a therapeutic antibody, demonstrating
that this approach can be used to engineer cells for more efﬁcient
recombinant protein expression.
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